This report contains market size and forecasts of Opioid Induced Constipation (OIC) Drugs in global, including the following market information:
Global Opioid Induced Constipation (OIC) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Opioid Induced Constipation (OIC) Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Opioid Induced Constipation (OIC) Drugs companies in 2021 (%)
The global Opioid Induced Constipation (OIC) Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lubiprostone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opioid Induced Constipation (OIC) Drugs include Ironwood Pharmaceuticals Inc, Daiichi Sankyo Co Ltd, Pfizer, Progenics Pharmaceuticals Inc, Shionogi & Co., Ltd, Allergan Plc, Nektar Therapeutics, Purdue Pharma and S.L.A. Pharma AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Induced Constipation (OIC) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioid Induced Constipation (OIC) Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation (OIC) Drugs Market Segment Percentages, by Type, 2021 (%)
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Global Opioid Induced Constipation (OIC) Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation (OIC) Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Opioid Induced Constipation (OIC) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Opioid Induced Constipation (OIC) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Opioid Induced Constipation (OIC) Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Opioid Induced Constipation (OIC) Drugs revenues share in global market, 2021 (%)
Key companies Opioid Induced Constipation (OIC) Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Opioid Induced Constipation (OIC) Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals